{
  "meta": {
    "title": "39_Parkinsons_Diseases_Other_Disorders",
    "url": "https://brainandscalpel.vercel.app/39-parkinsons-diseases-other-disorders-ad8be8f2.html",
    "scrapedAt": "2025-11-30T06:59:57.631Z"
  },
  "questions": [
    {
      "id": 98861,
      "choices": [
        {
          "id": 294290,
          "text": "Phenothiazine"
        },
        {
          "id": 294291,
          "text": "Selective serotonin reuptake inhibitor"
        },
        {
          "id": 294292,
          "text": "P blocker"
        },
        {
          "id": 294293,
          "text": "Azapirone"
        }
      ],
      "text": "Which of the following drugs is preferred for long term treatment of severe anxiety disorder with intermittent panic attacks?",
      "unique_key": "Q6851035",
      "question_audio": null,
      "question_video": null,
      "map_id": 34525295,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Selective serotonin reuptake inhibitor (SSRI) SSRIs are the first-line treatment for long-term management of severe anxiety disorders, including those with intermittent panic attacks. They work by increasing serotonin levels in the brain, which helps improve mood and reduce anxiety. Their favorable side-effect profile and proven efficacy in both generalized anxiety disorder and panic disorder make them the preferred choice for long-term treatment. Explanation of Incorrect Options: Option A (Phenothiazine): Phenothiazines are primarily used as antipsychotics and are not indicated for anxiety disorders. Their side effects, including sedation and extrapyramidal symptoms, make them unsuitable for the long-term management of anxiety. Option C (P blocker): Beta-blockers are sometimes used for the acute management of performance anxiety by reducing physical symptoms such as tachycardia and tremors. However, they do not address the core psychological aspects of anxiety or panic attacks and are not suitable for long-term treatment. Option D (Azapirone): Azapirones, such as buspirone, can be used for generalized anxiety disorder, but their efficacy in panic disorder is less established compared to SSRIs. Additionally, they typically require several weeks to take effect and may not be as robust in treating severe anxiety with intermittent panic attacks.",
      "correct_choice_id": 294291,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/53325371700138316/53325371700138316.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/53325371700138316/53325371700138316.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98862,
      "choices": [
        {
          "id": 294294,
          "text": "It interacts with benzodiazepine receptor as an inverse agonist"
        },
        {
          "id": 294295,
          "text": "It has anxiolytic but no anticonvulsants or muscle relaxant property"
        },
        {
          "id": 294296,
          "text": "It produces physical dependence and suppresses barbiturate withdrawal syndrome"
        },
        {
          "id": 294297,
          "text": "It is a rapidly acting anxiolytic: good for panic states"
        }
      ],
      "text": "All of the following statement» about buspirone are incorrect EXCEPT?",
      "unique_key": "Q5372397",
      "question_audio": null,
      "question_video": null,
      "map_id": 34222841,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) It has anxiolytic but no anticonvulsant or muscle relaxant property Buspirone is an anxiolytic drug that belongs to the azapirone class and is used primarily for the treatment of generalized anxiety disorder (GAD). Unlike benzodiazepines, buspirone does not act on GABA receptors and lacks sedative, anticonvulsant, or muscle relaxant properties. Mechanism of Action: It works by acting as a partial agonist at 5-HT1A receptors, modulating serotonin levels, which helps alleviate anxiety over time. Advantages: Buspirone has a low risk of dependence and withdrawal symptoms, making it a safer long-term option for anxiety management. Thus, Option B is the correct answer because buspirone has anxiolytic effects but lacks anticonvulsant or muscle relaxant activity. Explanation of Incorrect Options: Option A: \"It interacts with the benzodiazepine receptor as an inverse agonist\" Incorrect because buspirone does not act on benzodiazepine (GABA-A) receptors at all. Instead, it primarily affects serotonin (5-HT1A) receptors. Option C: \"It produces physical dependence and suppresses barbiturate withdrawal syndrome\" Incorrect because buspirone does not cause physical dependence or withdrawal symptoms. Unlike benzodiazepines or barbiturates, buspirone does not interact with GABAergic pathways, which are responsible for dependence and withdrawal. Option D: \"It is a rapidly acting anxiolytic: good for panic states\" Incorrect because buspirone has a delayed onset of action (typically 2-4 weeks). It is not effective for acute panic attacks, where benzodiazepines (e.g., alprazolam, diazepam) are preferred for rapid relief.",
      "correct_choice_id": 294295,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/23074321700138329/23074321700138329.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/23074321700138329/23074321700138329.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98863,
      "choices": [
        {
          "id": 294298,
          "text": "Parkinsonism"
        },
        {
          "id": 294299,
          "text": "Akathisia"
        },
        {
          "id": 294300,
          "text": "Tardive dyskinesia"
        },
        {
          "id": 294301,
          "text": "Acute muscle dystonia"
        }
      ],
      "text": "Propanolol is useful in the management of which of the following side effects of a typical neuroleptic?",
      "unique_key": "Q8382780",
      "question_audio": null,
      "question_video": null,
      "map_id": 34334625,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Akathisia Propranolol, a non-selective beta-blocker, is useful in managing akathisia, which is a common extrapyramidal side effect (EPS) of typical neuroleptics. Akathisia is characterized by: A subjective feeling of restlessness An inability to stay still Frequent pacing or shifting of legs Mechanism of action of Propranolol in Akathisia: Propranolol reduces adrenergic overactivity, which is believed to contribute to akathisia. It blocks beta-adrenergic receptors, helping to calm excessive movement and restlessness. Lipophilic beta-blockers (like propranolol) cross the blood-brain barrier, making them effective for neuroleptic-induced akathisia. Thus, Option B is the correct answer, as propranolol is the drug of choice for treating akathisia. Explanation of Incorrect Options: Option A: Parkinsonism Incorrect because propranolol does not alleviate Parkinsonian symptoms (e.g., rigidity, bradykinesia, tremors) caused by dopamine blockade. Anticholinergic drugs (e.g., benztropine, trihexyphenidyl) are the preferred treatment for neuroleptic-induced Parkinsonism. Option C: Tardive Dyskinesia (TD) Incorrect because propranolol has no significant role in treating tardive dyskinesia, which is a late-onset, involuntary movement disorder due to prolonged dopamine receptor blockade. VMAT2 inhibitors (e.g., valbenazine, deutetrabenazine) are more effective for TD. Option D: Acute Muscle Dystonia Incorrect because acute dystonia is best treated with anticholinergic agents (e.g., benztropine or diphenhydramine). Propranolol does not relieve dystonic reactions, which involve painful muscle spasms, often in the neck (torticollis) or eyes (oculogyric crisis).",
      "correct_choice_id": 294299,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/54664221700138345/54664221700138345.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/54664221700138345/54664221700138345.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98864,
      "choices": [
        {
          "id": 294302,
          "text": "Olanzapine"
        },
        {
          "id": 294303,
          "text": "Lithium"
        },
        {
          "id": 294304,
          "text": "Carbamazepine"
        },
        {
          "id": 294305,
          "text": "Valproic acid"
        }
      ],
      "text": "Which of the following drugs is both effective and safe to use in a pregnant patient suffering from bipolar disorder?",
      "unique_key": "Q8121551",
      "question_audio": null,
      "question_video": null,
      "map_id": 34525885,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Olanzapine Olanzapine is an atypical antipsychotic that is considered relatively safe and effective for use in pregnant patients with bipolar disorder. It has a low teratogenic risk compared to other mood stabilizers such as lithium, carbamazepine, and valproic acid. While it does have metabolic side effects, including weight gain and gestational diabetes risk, it is preferable to other options due to its lower potential for fetal harm. Explanation of Incorrect Options: Option B: Lithium Lithium is a mood stabilizer commonly used in bipolar disorder, but it is not considered safe during pregnancy due to its risk of Ebstein’s anomaly, a congenital heart defect affecting the tricuspid valve. Although lithium can sometimes be used in pregnancy when no other options are available, it requires frequent fetal monitoring and careful dosage adjustments. Option C: Carbamazepine Carbamazepine is teratogenic and can cause neural tube defects, craniofacial abnormalities, and developmental delay in the fetus. It is not the preferred choice for pregnant patients due to these risks. Option D: Valproic Acid Valproic acid is the most teratogenic of the options and is strongly contraindicated in pregnancy due to its association with neural tube defects (such as spina bifida), cardiac malformations, and neurodevelopmental disorders (fetal valproate syndrome). It should be completely avoided in pregnant patients unless no alternative is available.",
      "correct_choice_id": 294302,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/43229891700138716/43229891700138716.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/43229891700138716/43229891700138716.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98865,
      "choices": [
        {
          "id": 294306,
          "text": "Carbamazepine"
        },
        {
          "id": 294307,
          "text": "Primidone"
        },
        {
          "id": 294308,
          "text": "Lamotrigine"
        },
        {
          "id": 294309,
          "text": "Gabapentin"
        }
      ],
      "text": "An antiepileptic drug 'A' can also be used for the treatment of post-herpetic neuralgia and pain due to diabetic neuropathy. Which of the following can be the agent ‘A'?",
      "unique_key": "Q1382314",
      "question_audio": null,
      "question_video": null,
      "map_id": 34541750,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Gabapentin Gabapentin is an antiepileptic drug that is also widely used in the treatment of neuropathic pain, including post-herpetic neuralgia and diabetic neuropathy. Gabapentin works by modulating voltage-gated calcium channels, reducing excitatory neurotransmitter release, which helps in pain relief. It is particularly effective in chronic pain syndromes, making it a preferred choice for neuropathic pain management. Unlike many other antiepileptic drugs, gabapentin does not interact significantly with other medications, making it a safer choice for elderly and comorbid patients. Explanation of Incorrect Options: Option A: Carbamazepine Carbamazepine is an antiepileptic drug that is commonly used for trigeminal neuralgia, but it is not the first-line treatment for post-herpetic neuralgia or diabetic neuropathy. It works by blocking sodium channels, stabilizing hyperexcited nerve membranes. However, it has significant drug interactions and side effects, such as hyponatremia, bone marrow suppression, and hepatic toxicity. Option B: Primidone Primidone is an older antiepileptic drug that is mainly used to treat essential tremors and seizures. It does not have a significant role in neuropathic pain conditions like post-herpetic neuralgia or diabetic neuropathy. Option C: Lamotrigine Lamotrigine is an antiepileptic drug that is also used as a mood stabilizer in bipolar disorder. While it has some potential neuropathic pain applications, it is not the preferred drug for post-herpetic neuralgia or diabetic neuropathy. Additionally, serious side effects like Stevens-Johnson syndrome limit its widespread use in neuropathic pain management.",
      "correct_choice_id": 294309,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69847411700138749/69847411700138749.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69847411700138749/69847411700138749.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98866,
      "choices": [
        {
          "id": 294310,
          "text": "Metoclopramide"
        },
        {
          "id": 294311,
          "text": "Isoniazid"
        },
        {
          "id": 294312,
          "text": "Chlorpromazine"
        },
        {
          "id": 294313,
          "text": "Vitamin B complex"
        }
      ],
      "text": "A patient of parkinsonism, Mr. Ghai noticed that the therapeutic effect of levodopa decreased when he was given another drug by his physician but no interaction was seen when he switched over to levodopa-carbidopa combination. The possible drug prescribed by Ms. physician can be",
      "unique_key": "Q8459246",
      "question_audio": null,
      "question_video": null,
      "map_id": 34888440,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Vitamin B complex Levodopa, the precursor of dopamine, is used in the treatment of Parkinson’s disease. However, pyridoxine (Vitamin B6), which is present in Vitamin B complex supplements, enhances the peripheral metabolism of levodopa into dopamine before it reaches the brain. Since dopamine cannot cross the blood-brain barrier, this reduces the therapeutic effect of levodopa in Parkinson’s disease. When levodopa is combined with carbidopa, the issue is resolved because carbidopa inhibits peripheral dopa decarboxylase, preventing levodopa from being converted into dopamine outside the brain. This ensures that more levodopa reaches the CNS, thus preventing the negative effect of Vitamin B6. Explanation of Incorrect Options: Option A: Metoclopramide Incorrect because metoclopramide is a dopamine antagonist used for nausea and gastroparesis. It can worsen parkinsonian symptoms but does not directly affect levodopa metabolism like Vitamin B6. Option B: Isoniazid Incorrect because isoniazid does not interact significantly with levodopa. It mainly inhibits pyridoxine (Vitamin B6), which could theoretically enhance levodopa’s effects, rather than decrease them. Option C: Chlorpromazine Incorrect because chlorpromazine is a dopamine receptor blocker (antipsychotic) and can exacerbate Parkinson’s symptoms, but it does not reduce levodopa’s bioavailability. It acts centrally, while Vitamin B6 affects levodopa peripherally.",
      "correct_choice_id": 294313,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/38599361700139904/38599361700139904.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/38599361700139904/38599361700139904.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98867,
      "choices": [
        {
          "id": 294314,
          "text": "Reserpine"
        },
        {
          "id": 294315,
          "text": "Diazepam"
        },
        {
          "id": 294316,
          "text": "Ketamine"
        },
        {
          "id": 294317,
          "text": "Baclofen"
        }
      ],
      "text": "A compound X decreases the functional activities of several CNS neurotransmitters including dopamine, adrenaline and serotonin at high doses it may cause Parkinsonism like extrapyramidal system dysfunction. Which of the following can be X?",
      "unique_key": "Q2378420",
      "question_audio": null,
      "question_video": null,
      "map_id": 34534076,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Reserpine Reserpine is a drug that depletes neurotransmitters such as dopamine, norepinephrine (adrenaline), and serotonin from nerve terminals by irreversibly inhibiting vesicular monoamine transporter (VMAT-2). This leads to decreased neurotransmitter levels in the central nervous system (CNS) and peripheral nervous system. At high doses, reserpine can cause extrapyramidal symptoms (EPS) resembling Parkinsonism, due to dopamine depletion in the basal ganglia. This results in symptoms like rigidity, tremors, and bradykinesia, which are characteristic of Parkinson’s disease. Explanation of Incorrect Options: Option B: Diazepam Incorrect because diazepam is a benzodiazepine, which enhances GABAergic inhibition in the CNS. It has no role in depleting dopamine or other monoamines and does not cause Parkinsonism-like symptoms. Instead, it reduces muscle rigidity and is sometimes used to treat Parkinsonian tremors. Option C: Ketamine Incorrect because ketamine is a NMDA receptor antagonist that works as an anesthetic and dissociative agent. It does not affect dopamine, serotonin, or norepinephrine in a way that would cause Parkinsonism. Instead, ketamine is being explored for antidepressant effects due to its impact on glutamate transmission. Option D: Baclofen Incorrect because baclofen is a GABA-B agonist used primarily as a muscle relaxant for conditions like spasticity. It does not deplete dopamine or cause extrapyramidal side effects. In fact, it is sometimes used to manage certain motor disorders rather than inducing them.",
      "correct_choice_id": 294314,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26387891700139924/26387891700139924.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26387891700139924/26387891700139924.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98868,
      "choices": [
        {
          "id": 294318,
          "text": "Benserazide"
        },
        {
          "id": 294319,
          "text": "Entacapone"
        },
        {
          "id": 294320,
          "text": "Pramipexole"
        },
        {
          "id": 294321,
          "text": "Selegiline"
        }
      ],
      "text": "Which of the following antiparkinsonian drugs directly activates dopaminergic D2 receptors in the striatum?",
      "unique_key": "Q2866607",
      "question_audio": null,
      "question_video": null,
      "map_id": 34312969,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Pramipexole Pramipexole is a non-ergot dopamine agonist that directly stimulates dopaminergic D2 and D3 receptors in the striatum, compensating for the loss of dopamine in Parkinson’s disease. By acting directly on these receptors, pramipexole helps reduce motor symptoms like bradykinesia, rigidity, and tremors. Unlike levodopa, which requires enzymatic conversion to dopamine, pramipexole bypasses dopamine synthesis and directly activates dopamine receptors, leading to a more stable response and fewer motor fluctuations. Explanation of Incorrect Options: Option A: Benserazide Benserazide is a peripheral dopa decarboxylase inhibitor. It is combined with levodopa (as co-beneldopa) to prevent peripheral conversion of levodopa into dopamine, thereby increasing its availability in the brain. It does not directly activate D2 receptors. Option B: Entacapone Entacapone is a COMT (catechol-O-methyltransferase) inhibitor. It prolongs the effect of levodopa by preventing its breakdown but does not stimulate D2 receptors directly. Option D: Selegiline Selegiline is a selective MAO-B inhibitor, which prevents dopamine breakdown in the brain and enhances dopaminergic activity. However, it does not directly activate D2 receptors.",
      "correct_choice_id": 294320,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/39782901700139957/39782901700139957.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/39782901700139957/39782901700139957.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98869,
      "choices": [
        {
          "id": 294322,
          "text": "On-off effect"
        },
        {
          "id": 294323,
          "text": "Nausea and vomiting"
        },
        {
          "id": 294324,
          "text": "Cardiac arrhythmia"
        },
        {
          "id": 294325,
          "text": "Involuntary movements"
        }
      ],
      "text": "Which of the following adverse effects of levodopa is not minimized even after combining it with carbidopa?",
      "unique_key": "Q1839931",
      "question_audio": null,
      "question_video": null,
      "map_id": 34138575,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Involuntary movements Levodopa, when used for Parkinson’s disease, is often combined with carbidopa to inhibit peripheral dopa decarboxylase, which prevents levodopa's premature conversion to dopamine outside the brain. This increases the availability of levodopa in the CNS, allowing lower doses and reducing certain peripheral side effects. However, involuntary movements (dyskinesias) remain a major side effect of long-term levodopa use, even when combined with carbidopa. These dyskinesias occur due to dopamine receptor hypersensitivity in the striatum and fluctuations in dopamine levels, which carbidopa does not prevent. This is a significant limitation in Parkinson’s treatment, especially in advanced stages. Explanation of Incorrect Options: Option A: On-off effect The on-off phenomenon refers to sudden fluctuations in motor function, with “on” periods of good mobility and “off” periods of rigidity and bradykinesia. This is due to progressive loss of dopamine neurons and irregular absorption of levodopa. While carbidopa can help stabilize levodopa levels to some extent, the on-off effect still occurs, but it can be managed with controlled-release formulations or dopamine agonists. Option B: Nausea and vomiting Levodopa causes nausea and vomiting due to peripheral dopamine action on the chemoreceptor trigger zone (CTZ) in the medulla. Since carbidopa prevents peripheral dopamine formation, it significantly reduces nausea and vomiting. Option C: Cardiac arrhythmia Levodopa can lead to cardiac arrhythmias due to peripheral dopamine effects increasing catecholamine levels. Since carbidopa reduces peripheral dopamine formation, it also lowers the risk of cardiac arrhythmias.",
      "correct_choice_id": 294325,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/38661091700140069/38661091700140069.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/38661091700140069/38661091700140069.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98870,
      "choices": [
        {
          "id": 294326,
          "text": "Activates COMT"
        },
        {
          "id": 294327,
          "text": "Inhibits dopamine uptake"
        },
        {
          "id": 294328,
          "text": "Inhibits monoamine oxidase type B"
        },
        {
          "id": 294329,
          "text": "Decreases formation of 3-OMD"
        }
      ],
      "text": "Entacapone may be useful in patients being treated with levodopa carbidopa combination because it.",
      "unique_key": "Q7358537",
      "question_audio": null,
      "question_video": null,
      "map_id": 34711280,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Decreases formation of 3-OMD Entacapone is a catechol-O-methyltransferase (COMT) inhibitor used in conjunction with levodopa-carbidopa therapy for Parkinson’s disease. One major issue with levodopa treatment is its peripheral metabolism, leading to the formation of 3-O-methyldopa (3-OMD), a metabolite that competes with levodopa for transport across the blood-brain barrier (BBB). By inhibiting COMT, entacapone reduces the formation of 3-OMD, thereby increasing the availability and effectiveness of levodopa in the central nervous system, leading to better symptom control. Incorrect Options: (A) Activates COMT – Incorrect Entacapone does not activate COMT; instead, it inhibits the enzyme. COMT is responsible for the breakdown of catecholamines, including levodopa, and its inhibition prolongs levodopa's effects. (B) Inhibits dopamine uptake – Incorrect Entacapone does not directly inhibit dopamine uptake at synapses. Its primary function is to prevent peripheral metabolism of levodopa, increasing its bioavailability rather than affecting dopamine reuptake in the brain. (C) Inhibits monoamine oxidase type B – Incorrect Entacapone does not inhibit monoamine oxidase type B (MAO-B). MAO-B inhibitors like selegiline and rasagiline are used in Parkinson’s disease to prevent dopamine breakdown in the brain, whereas entacapone acts in the periphery by inhibiting COMT.",
      "correct_choice_id": 294329,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40455981700140096/40455981700140096.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40455981700140096/40455981700140096.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98871,
      "choices": [
        {
          "id": 294330,
          "text": "Dexamethasone"
        },
        {
          "id": 294331,
          "text": "Dronabinol"
        },
        {
          "id": 294332,
          "text": "Levodopa"
        },
        {
          "id": 294333,
          "text": "Ondansetron"
        }
      ],
      "text": "A patient is receiving chemotherapy for metastatic carcinoma. She threatens to stop her treatment because of severe nausea and vomiting. Which one of the following drugs is not likely to prevent such chemotherapy-induced nausea and vomiting?",
      "unique_key": "Q2315549",
      "question_audio": null,
      "question_video": null,
      "map_id": 34644805,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Levodopa. Explanation for the Correct Answer: Levodopa is a dopamine precursor used primarily in the treatment of Parkinson’s disease. It is not an antiemetic and does not help prevent chemotherapy-induced nausea and vomiting (CINV). In fact, dopamine agonism in the chemoreceptor trigger zone (CTZ) can worsen nausea, making levodopa a poor choice for managing CINV. Chemotherapy-induced nausea and vomiting is mediated by activation of the chemoreceptor trigger zone (CTZ) and vomiting center in the brainstem, which involves serotonin (5-HT3), dopamine (D2), and neurokinin (NK1) receptors. Since levodopa increases dopamine levels, it may even exacerbate nausea and vomiting, making it completely ineffective in this scenario. Incorrect Answers: A) Dexamethasone: Glucocorticoids like dexamethasone are commonly used as adjuncts to other antiemetics in chemotherapy-induced nausea and vomiting. They reduce inflammation, modulate neurotransmitter activity, and enhance the effectiveness of 5-HT3 receptor antagonists like ondansetron. Dexamethasone is especially useful in delayed CINV, making it an effective choice. B) Dronabinol: Dronabinol is a cannabinoid receptor agonist (synthetic THC) that helps reduce nausea and stimulate appetite. It is approved for use in chemotherapy-induced nausea and vomiting when other antiemetics fail. Its central action on the cannabinoid receptors in the vomiting center makes it a viable antiemetic. D) Ondansetron: Ondansetron is a 5-HT3 receptor antagonist and one of the most effective antiemetics for CINV. It works by blocking serotonin receptors in the chemoreceptor trigger zone (CTZ) and the vagus nerve, preventing both acute nausea and vomiting. It is considered a first-line treatment for CINV.",
      "correct_choice_id": 294332,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/66846781700305582/66846781700305582.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/66846781700305582/66846781700305582.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98872,
      "choices": [
        {
          "id": 294334,
          "text": "Asenapine"
        },
        {
          "id": 294335,
          "text": "Cariprazine"
        },
        {
          "id": 294336,
          "text": "Lurasidone"
        },
        {
          "id": 294337,
          "text": "Pimavanserin"
        }
      ],
      "text": "A 70 year old parkinsons disease patient suffering from severe disease, refractory to most of anti parkinsonism drug, has been kept on high dose levodopa therapy to improve quality of life. Now this patient is presented in OPD with delusion of spouse infedility and visual hallucinations. Which of the following antipsychotic is best to start to manage the above complication ?",
      "unique_key": "Q6368694",
      "question_audio": null,
      "question_video": null,
      "map_id": 34312266,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Pimavanserin Explanation for the Correct Answer: The patient is suffering from Parkinson’s disease psychosis (PDP), characterized by delusions and visual hallucinations. This condition often arises due to the dopaminergic overactivity from high-dose levodopa therapy, which is used to control severe Parkinson’s symptoms. Pimavanserin is the best choice because it is specifically approved for treating Parkinson’s disease psychosis (PDP) without worsening motor symptoms. It acts as a selective serotonin 5-HT2A inverse agonist with minimal dopamine receptor blockade, reducing psychosis while preserving motor function. Unlike typical or atypical antipsychotics, Pimavanserin does not worsen Parkinson’s symptoms, making it the preferred option. Explanation for the Incorrect Answers: (A) Asenapine Asenapine is an atypical antipsychotic with dopamine D2 and serotonin 5-HT2A antagonism. Although it has a better safety profile than first-generation antipsychotics, it still has D2 blockade, which can worsen Parkinson’s motor symptoms. Therefore, it is not the best option for PDP. (B) Cariprazine Cariprazine is a dopamine D2/D3 partial agonist with additional serotonin activity. While it has less potential for motor side effects than traditional antipsychotics, it still blocks dopamine receptors, which may worsen Parkinson’s disease symptoms. Thus, it is not the preferred option. (C) Lurasidone Lurasidone is a dopamine D2 and serotonin 5-HT2A antagonist, making it effective for schizophrenia and bipolar depression. However, D2 receptor blockade can worsen Parkinsonian symptoms and lead to motor deterioration. Therefore, it is not the best choice for Parkinson’s disease psychosis.",
      "correct_choice_id": 294337,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42121351700305706/42121351700305706.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42121351700305706/42121351700305706.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98873,
      "choices": [
        {
          "id": 294338,
          "text": "Valbenazine"
        },
        {
          "id": 294339,
          "text": "Dalfampridine"
        },
        {
          "id": 294340,
          "text": "Edaravone"
        },
        {
          "id": 294341,
          "text": "Atomexitine"
        }
      ],
      "text": "A 48 year old females comes to neurology OPD with symptoms of hyperreflexia, and spasticity as well as atrophy of muscles and fasciculations. Which of the following drug can slow down the course of above disease ?",
      "unique_key": "Q3849497",
      "question_audio": null,
      "question_video": null,
      "map_id": 34311053,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Edaravone Explanation for the Correct Answer: The patient's symptoms—hyperreflexia, spasticity, muscle atrophy, and fasciculations—are characteristic of Amyotrophic Lateral Sclerosis (ALS). ALS is a progressive neurodegenerative disease that affects both upper and lower motor neurons. Edaravone is one of the few drugs that can slow down the progression of ALS by: Acting as a free radical scavenger to reduce oxidative stress, which is believed to contribute to motor neuron degeneration in ALS. Delaying functional decline in ALS patients, as demonstrated in clinical trials. Being FDA-approved for ALS treatment, alongside Riluzole, which also slows disease progression. While Edaravone does not cure ALS, it can help preserve motor function for a longer period by protecting neurons from oxidative damage. Explanation for the Incorrect Answers: (A) Valbenazine Used for tardive dyskinesia, a movement disorder caused by chronic antipsychotic use. Does not have any role in slowing ALS progression. (B) Dalfampridine A potassium channel blocker used to improve walking ability in multiple sclerosis (MS). Has no neuroprotective effect in ALS. (D) Atomoxetine A norepinephrine reuptake inhibitor (NRI) used in attention-deficit hyperactivity disorder (ADHD). Has no known benefit in ALS.",
      "correct_choice_id": 294340,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26270221700305738/26270221700305738.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26270221700305738/26270221700305738.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98874,
      "choices": [
        {
          "id": 294342,
          "text": "Levodopa"
        },
        {
          "id": 294343,
          "text": "Selegiline"
        },
        {
          "id": 294344,
          "text": "Pramipexole"
        },
        {
          "id": 294345,
          "text": "Amantadine"
        }
      ],
      "text": "A 60 year old patient is diagnosed with Parkinsons disease but having mild symptoms which are minimally affecting his quality of life. Which of the following is the best drug to start treatment in above patient?",
      "unique_key": "Q1716462",
      "question_audio": null,
      "question_video": null,
      "map_id": 34025442,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Selegiline Explanation for the Correct Answer: The patient has mild Parkinson’s disease (PD) symptoms that are minimally affecting quality of life. In such cases, the best approach is to delay the introduction of Levodopa, as its long-term use is associated with motor fluctuations and dyskinesias. Selegiline, a selective MAO-B inhibitor, is a preferred initial treatment in mild Parkinson’s disease because: It inhibits monoamine oxidase-B (MAO-B), preventing dopamine breakdown in the brain. It mildly improves motor symptoms and may delay the need for Levodopa therapy. It has neuroprotective properties, potentially slowing disease progression. For patients with minimal impact on daily life, MAO-B inhibitors like Selegiline or Rasagiline are recommended as first-line therapy. Explanation for the Incorrect Answers: (A) Levodopa (also repeated as option D) Levodopa is the most effective drug for Parkinson’s disease, but it is not the best first-line treatment in early, mild cases. Long-term use leads to motor complications (fluctuations, dyskinesia). It is reserved for when symptoms significantly impact daily activities. (C) Pramipexole A dopamine agonist, effective in early Parkinson’s disease but can cause side effects like impulse control disorders (e.g., gambling, hypersexuality), hallucinations, and daytime sleepiness. More suitable for younger patients (< 60 years old) due to lower risk of motor complications compared to Levodopa.",
      "correct_choice_id": 294343,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/48637851700305752/48637851700305752.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/48637851700305752/48637851700305752.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98875,
      "choices": [
        {
          "id": 294346,
          "text": "Serum Electrolytes"
        },
        {
          "id": 294347,
          "text": "Serum lithium levels"
        },
        {
          "id": 294348,
          "text": "ECG"
        },
        {
          "id": 294349,
          "text": "MRI"
        }
      ],
      "text": "A female patient was on lithium therapy for bipolar disorder for 6 months.She kept the fast for few days due to religious reasons and presented with seizures, coarse tremors, confusion and weakness of limbs. Which of the following should be done to diagnose her condition?",
      "unique_key": "Q6517399",
      "question_audio": null,
      "question_video": null,
      "map_id": 34313687,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Serum Lithium Levels Explanation for the Correct Answer: The patient, who has been on lithium therapy for bipolar disorder, developed neurological symptoms (seizures, coarse tremors, confusion, limb weakness) after fasting for a few days. This suggests lithium toxicity, which can occur due to dehydration, sodium depletion, or reduced renal clearance. Lithium has a narrow therapeutic index (0.6–1.2 mEq/L), and toxicity occurs at levels above 1.5 mEq/L. Risk factors for toxicity include dehydration, fasting, sodium depletion, and renal impairment, all of which can reduce lithium excretion. Symptoms of mild toxicity include nausea, vomiting, diarrhea, tremors, while moderate to severe toxicity presents with confusion, ataxia, seizures, and coma. Serum lithium levels should be measured immediately to confirm toxicity and guide treatment (e.g., hydration, hemodialysis if levels are dangerously high). Explanation for the Incorrect Answers: (A) Serum Electrolytes Electrolyte imbalances (e.g., hyponatremia, hypokalemia) can cause neurological symptoms, but they do not specifically diagnose lithium toxicity. Hyponatremia can exacerbate lithium toxicity, but serum lithium levels are the primary diagnostic test. (C) ECG Lithium can cause cardiac toxicity (e.g., sinus bradycardia, T-wave flattening, QT prolongation), but ECG findings are not diagnostic of lithium toxicity. ECG may be useful in severe cases but does not replace serum lithium level measurement. (D) MRI MRI is not required for diagnosing lithium toxicity. Chronic lithium use can lead to neurological changes, but MRI is not the first-line investigation for acute toxicity.",
      "correct_choice_id": 294347,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7565701700305771/7565701700305771.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7565701700305771/7565701700305771.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98876,
      "choices": [
        {
          "id": 294350,
          "text": "Venlafexine"
        },
        {
          "id": 294351,
          "text": "Fluoxetine"
        },
        {
          "id": 294352,
          "text": "Amitryptiline"
        },
        {
          "id": 294353,
          "text": "Duloxetine"
        }
      ],
      "text": "A 52 year old unmarried female suffering from breast cancer and taking adjuvant hormonal therapy tab tamoxifen 20 mg per day as her treatment course. Her mother and two sisters died because of breast cancer and she has also lost all hope to live due to her disease. As a physician you want to improve quality of her life and would like to initiate anti depressant treatment . Which of the following is the best choice for this patient to start treatment with ?",
      "unique_key": "Q9551693",
      "question_audio": null,
      "question_video": null,
      "map_id": 34701270,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Venlafaxine Explanation for the Correct Answer: Venlafaxine is the preferred antidepressant for this patient because it is a serotonin-norepinephrine reuptake inhibitor (SNRI) that effectively treats depression, anxiety, and vasomotor symptoms (hot flashes) associated with tamoxifen therapy. Tamoxifen is a selective estrogen receptor modulator (SERM) used in breast cancer treatment. It requires activation by the CYP2D6 enzyme to form its active metabolite, endoxifen, which is crucial for its anticancer effects. Venlafaxine has minimal CYP2D6 inhibition, making it safe to use with tamoxifen while effectively managing depression and hot flashes. This makes venlafaxine the best option for this patient, as it provides both antidepressant and vasomotor symptom relief without interfering with tamoxifen metabolism. Explanation for the Incorrect Answers: (B) Fluoxetine Incorrect because fluoxetine is a strong CYP2D6 inhibitor. It significantly reduces endoxifen formation, potentially compromising the efficacy of tamoxifen in breast cancer treatment. Though fluoxetine is a common SSRI for depression, it should be avoided in patients on tamoxifen. (C) Amitriptyline Incorrect because it is a tricyclic antidepressant (TCA) with strong CYP2D6 inhibition. Like fluoxetine, it can reduce the therapeutic effects of tamoxifen by decreasing endoxifen levels. Additionally, TCAs have significant anticholinergic side effects (sedation, dry mouth, constipation, weight gain), which can worsen quality of life in cancer patients. (D) Duloxetine Incorrect because it is a moderate CYP2D6 inhibitor, though weaker than fluoxetine and amitriptyline. While it is an SNRI like venlafaxine, its interaction with tamoxifen makes it a less preferred option. Duloxetine is often used for neuropathic pain and fibromyalgia, but venlafaxine is the better choice for this patient's condition.",
      "correct_choice_id": 294350,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/22735811700306040/22735811700306040.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/22735811700306040/22735811700306040.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98877,
      "choices": [
        {
          "id": 294354,
          "text": "Drug toxicity"
        },
        {
          "id": 294355,
          "text": "Retroperitoneal fibrosis"
        },
        {
          "id": 294356,
          "text": "Renal artery thrombosis"
        },
        {
          "id": 294357,
          "text": "Renal vein thrombosis"
        }
      ],
      "text": "A 63-year-old man has been diagnosed with Parkinson’s disease, the physician starts him on a course of bromocriptine in hope of improving his significant symptoms of cogwheel rigidity and bradykinesia. After being on the medication for 6 months, a renal ultrasound is obtained that reveals bilateral hydronephrosis and elevation of his serum creatinine to 2.5 mg/dL. What is the most likely explanation for these findings?",
      "unique_key": "Q2706430",
      "question_audio": null,
      "question_video": null,
      "map_id": 34495469,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Retroperitoneal Fibrosis Explanation for the Correct Answer: Bromocriptine is a dopamine agonist used in the treatment of Parkinson’s disease. However, one of its well-known side effects is retroperitoneal fibrosis (RPF), a rare but serious complication. Mechanism of Retroperitoneal Fibrosis (RPF): Bromocriptine, like other ergot-derived dopamine agonists (e.g., pergolide, cabergoline), has been associated with fibrotic reactions in various tissues, including the retroperitoneal space, heart valves, and lungs. RPF involves chronic inflammation and fibrosis of the retroperitoneum, leading to compression of ureters, which results in bilateral hydronephrosis and ultimately renal dysfunction. Elevated serum creatinine (2.5 mg/dL) in this patient suggests significant obstruction and impaired renal function. Thus, the most likely explanation for his bilateral hydronephrosis and renal dysfunction is retroperitoneal fibrosis caused by bromocriptine. Explanation for the Incorrect Answers: (A) Drug Toxicity – Incorrect While bromocriptine can have side effects, it is not directly nephrotoxic. Nephrotoxicity usually presents with acute tubular necrosis or interstitial nephritis, neither of which is suggested by the presence of hydronephrosis. The presence of bilateral hydronephrosis suggests a mechanical obstruction rather than direct drug toxicity. (C) Renal Artery Thrombosis – Incorrect Renal artery thrombosis would cause acute kidney injury (AKI) with sudden-onset flank pain, hematuria, and severe hypertension rather than gradual deterioration of renal function. It would typically lead to unilateral kidney dysfunction unless both renal arteries are affected, which is rare. The bilateral hydronephrosis seen in this patient does not fit with renal artery thrombosis, which primarily affects renal perfusion rather than urinary outflow. (D) Renal Vein Thrombosis – Incorrect Renal vein thrombosis is most commonly associated with nephrotic syndrome, dehydration, or hypercoagulable states. It typically presents with sudden flank pain, hematuria, and an enlarged kidney on imaging, rather than the gradual obstruction leading to hydronephrosis seen in this case. Unlike RPF, renal vein thrombosis does not cause progressive ureteral obstruction.",
      "correct_choice_id": 294355,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/54366441700305133/54366441700305133.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/54366441700305133/54366441700305133.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98878,
      "choices": [
        {
          "id": 294358,
          "text": "Carbamazepine"
        },
        {
          "id": 294359,
          "text": "Ethosuximide"
        },
        {
          "id": 294360,
          "text": "Felbamate"
        },
        {
          "id": 294361,
          "text": "Gabapentin"
        }
      ],
      "text": "A 48-year-old woman has a history of seizure disorder, bipolar disorder, and trigeminal neuralgia, she presents to her physician’s clinic for follow-up and treatment. She has no new complaints. Which of the following medications may serve to treat all of her earlier mentioned problems?",
      "unique_key": "Q2165320",
      "question_audio": null,
      "question_video": null,
      "map_id": 34654967,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Carbamazepine Carbamazepine is an anticonvulsant that is particularly effective in treating seizures, bipolar disorder, and trigeminal neuralgia, making it the most appropriate medication for this patient with a history of all three conditions. It works by inhibiting voltage-gated sodium channels, which reduces neuronal excitability. For seizures, it is a first-line treatment for focal and generalized tonic-clonic seizures. In bipolar disorder, carbamazepine is used as a mood stabilizer, particularly in the acute treatment of mania. Additionally, carbamazepine is considered the first-line treatment for trigeminal neuralgia, as it effectively reduces the sharp, shooting pain associated with the condition. Incorrect Options: B. Ethosuximide Ethosuximide is primarily used to treat absence seizures and is not effective in treating bipolar disorder or trigeminal neuralgia. While it is an appropriate choice for certain types of epilepsy, it does not have the broad indications needed for this patient’s multiple conditions, making it unsuitable for this case. C. Felbamate Felbamate is an anticonvulsant used primarily in refractory epilepsy, particularly for partial seizures and Lennox-Gastaut syndrome. However, it is not a first-line treatment for bipolar disorder or trigeminal neuralgia. Due to its risk profile, including potentially severe side effects like hepatotoxicity and aplastic anemia, it is not typically considered for long-term management of bipolar disorder or trigeminal neuralgia. Therefore, felbamate is not an appropriate treatment for this patient’s conditions. D. Gabapentin Gabapentin is used to treat conditions like peripheral neuropathy, postherpetic neuralgia, and sometimes seizures, but it is not typically used to treat bipolar disorder. Although it is effective for trigeminal neuralgia, carbamazepine is more commonly preferred due to its better-established efficacy. Additionally, gabapentin does not provide the mood-stabilizing effects needed for bipolar disorder, which makes it less suitable for this patient.",
      "correct_choice_id": 294358,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/19790661700305198/19790661700305198.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/19790661700305198/19790661700305198.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98879,
      "choices": [
        {
          "id": 294362,
          "text": "Carbamazepine"
        },
        {
          "id": 294363,
          "text": "Phenobarbital"
        },
        {
          "id": 294364,
          "text": "Phenytoin"
        },
        {
          "id": 294365,
          "text": "Pregabalin"
        }
      ],
      "text": "A 52 -year-old man having seizure disorder and chronic neuropathic pain presents to neurology OPD for follow-up. Review of his laboratory studies indicates elevated liver function tests to four times the normal levels. Which of the following agents would be preferred to manage this patient?",
      "unique_key": "Q3351799",
      "question_audio": null,
      "question_video": null,
      "map_id": 34973739,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Pregabalin Pregabalin is the preferred treatment for this patient with both seizure disorder and chronic neuropathic pain, especially in the context of elevated liver function tests. Pregabalin is a gamma-aminobutyric acid (GABA) analogue that is effective for neuropathic pain and can also be used as an adjunctive treatment for seizures. It is primarily metabolized by the kidneys rather than the liver, which makes it a safer option in patients with liver dysfunction or elevated liver enzymes. This is important in this case because the other anticonvulsant options have potential hepatotoxic effects and could worsen the liver function issues. Incorrect Options: A. Carbamazepine Carbamazepine is an effective treatment for both seizures and neuropathic pain, particularly trigeminal neuralgia. However, carbamazepine is metabolized in the liver and has been associated with hepatotoxicity. Given that this patient already has elevated liver enzymes, carbamazepine would not be the best choice, as it could potentially exacerbate liver damage. This makes carbamazepine a less ideal option in this scenario. B. Phenobarbital Phenobarbital is another anticonvulsant used for seizure management, and it has sedative properties that may also help with certain types of pain. However, it is also metabolized by the liver and can be hepatotoxic, especially with long-term use. Given the patient’s existing liver dysfunction, phenobarbital would not be the best choice. Additionally, it is less commonly used nowadays due to the availability of more effective and better-tolerated drugs. C. Phenytoin Phenytoin is widely used to control seizures, but it also has the potential for liver toxicity, particularly with prolonged use or high doses. Like carbamazepine, phenytoin is metabolized by the liver and can elevate liver enzymes. This makes it less suitable for a patient with significantly elevated liver function tests. Given the patient’s liver concerns, phenytoin would not be the preferred treatment in this case.",
      "correct_choice_id": 294365,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/53480961700305225/53480961700305225.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/53480961700305225/53480961700305225.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98880,
      "choices": [
        {
          "id": 294366,
          "text": "Decreased acetylcholine"
        },
        {
          "id": 294367,
          "text": "Decreased dopamine"
        },
        {
          "id": 294368,
          "text": "Decreased norepinephrine"
        },
        {
          "id": 294369,
          "text": "Increased acetylcholine"
        }
      ],
      "text": "A 70-year-old man is brought to the hospital by his son. The son complains that this patient has been becoming forgetful, confused, moody, and aggressive over the past few months. Which of the following neurotransmitter changes is characteristic of Alzheimer’s disease?",
      "unique_key": "Q4029753",
      "question_audio": null,
      "question_video": null,
      "map_id": 34585947,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Decreased acetylcholine. Alzheimer’s disease (AD) is characterized by progressive cognitive decline, including memory loss, confusion, and behavioral changes. A key pathological hallmark of AD is the degeneration of cholinergic neurons in the basal forebrain, particularly in the nucleus basalis of Meynert, which provides widespread cholinergic innervation to the cerebral cortex. This leads to a significant reduction in acetylcholine (ACh) levels, which is crucial for learning and memory. This cholinergic deficiency is a major contributor to cognitive impairment in AD. As a result, acetylcholinesterase inhibitors (e.g., donepezil, rivastigmine, and galantamine) are used as symptomatic treatments to enhance cholinergic transmission in AD patients. Explanation of Incorrect Options: (B) Decreased dopamine: Dopamine reduction is primarily associated with Parkinson’s disease rather than Alzheimer’s disease. In Parkinson’s disease, degeneration of dopaminergic neurons in the substantia nigra pars compacta leads to motor symptoms such as bradykinesia, rigidity, and tremors. While some Alzheimer’s patients may develop Parkinsonian features, dopamine depletion is not a defining neurotransmitter change in AD. (C) Decreased norepinephrine: Norepinephrine is primarily produced by the locus coeruleus, and its decline is more commonly linked to depression and stress-related disorders. While some studies suggest that AD patients may have some degree of norepinephrine reduction, it is not the primary neurotransmitter abnormality responsible for the hallmark cognitive deficits of the disease. (D) Increased acetylcholine: This is the opposite of what occurs in Alzheimer’s disease. Rather than an increase, there is a marked decrease in acetylcholine due to the degeneration of cholinergic neurons. Increased acetylcholine would theoretically enhance memory and cognition, which is why acetylcholinesterase inhibitors are used to increase cholinergic activity in AD patients.",
      "correct_choice_id": 294366,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/39143161700305240/39143161700305240.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/39143161700305240/39143161700305240.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98881,
      "choices": [
        {
          "id": 294370,
          "text": "Anti-inflammatory to decrease muscle pain"
        },
        {
          "id": 294371,
          "text": "Decrease heartburn"
        },
        {
          "id": 294372,
          "text": "Relieve muscle spasms"
        },
        {
          "id": 294373,
          "text": "Reverse the progression of MS"
        }
      ],
      "text": "A 30 -year-old woman presents to the clinic. She has been diagnosed with multiple sclerosis, her complaints are muscle rigidity and spasms. She also complains of difficulty sleeping, heartburn, and muscle pain. One of the drugs her physician prescribes is baclofen. Which of the following will baclofen do for this patient?",
      "unique_key": "Q1306352",
      "question_audio": null,
      "question_video": null,
      "map_id": 34507693,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Relieve muscle spasms. Baclofen is a GABA_B receptor agonist that acts as a central muscle relaxant, primarily used to treat spasticity associated with conditions like multiple sclerosis (MS), spinal cord injuries, and cerebral palsy. Spasticity in MS occurs due to demyelination of neurons in the central nervous system, leading to hyperactive reflexes and involuntary muscle contractions. Baclofen works by inhibiting excitatory neurotransmitter release in the spinal cord, thereby reducing muscle rigidity, spasms, and improving mobility. This helps patients with MS manage their symptoms, improving comfort, function, and quality of life. Explanation of Incorrect Options: (A) Anti-inflammatory to decrease muscle pain: Baclofen is not an anti-inflammatory drug. While it helps relieve muscle spasms, it does not directly reduce inflammation or pain. Nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or corticosteroids are typically used for inflammatory conditions. (B) Decrease heartburn: Baclofen has been investigated for gastroesophageal reflux disease (GERD) because it can reduce lower esophageal sphincter relaxation, thereby decreasing acid reflux. However, its primary use is for muscle spasticity, and it is not a first-line treatment for heartburn. Proton pump inhibitors (PPIs) like omeprazole or H2 blockers like ranitidine are more effective for this condition. (D) Reverse the progression of MS: Multiple sclerosis is a chronic autoimmune demyelinating disease of the central nervous system, and baclofen does not modify or reverse its progression. Disease-modifying therapies (DMTs) like interferon-beta, natalizumab, or fingolimod are used to slow disease progression and reduce relapses, but baclofen is only used for symptom management.",
      "correct_choice_id": 294372,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/61939771700305273/61939771700305273.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/61939771700305273/61939771700305273.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98882,
      "choices": [
        {
          "id": 294374,
          "text": "Increase dopamine production"
        },
        {
          "id": 294375,
          "text": "Inhibit acetylcholinesterase"
        },
        {
          "id": 294376,
          "text": "Stimulate acetylcholine receptors"
        },
        {
          "id": 294377,
          "text": "Stimulate dopamine receptors"
        }
      ],
      "text": "A 59-year-old man presents to the medicine OPD with a shuffling gait, cogwheel rigidity, and a resting tremor. His physician prescribes levodopa and his symptoms greatly improve, supporting a diagnosis of Parkinson’s disease. How does levodopa help this patient’s symptoms?",
      "unique_key": "Q7599469",
      "question_audio": null,
      "question_video": null,
      "map_id": 34992024,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Increase dopamine production. Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to motor symptoms such as resting tremor, bradykinesia, rigidity, and postural instability. Since dopamine itself cannot cross the blood-brain barrier (BBB), levodopa (L-DOPA), a dopamine precursor, is administered. Once in the brain, levodopa is converted into dopamine by the enzyme dopa decarboxylase, thereby replenishing dopamine levels in the basal ganglia and improving motor symptoms. Levodopa is typically co-administered with carbidopa, a peripheral dopa decarboxylase inhibitor, to prevent premature conversion of levodopa into dopamine in the periphery, ensuring more levodopa reaches the brain. Explanation of Incorrect Options: (B) Inhibit acetylcholinesterase: Acetylcholinesterase inhibitors (e.g., donepezil, rivastigmine, galantamine) work by increasing acetylcholine levels and are primarily used to treat Alzheimer’s disease, not Parkinson’s disease. In Parkinson’s, there is an imbalance between dopamine (low) and acetylcholine (relatively high), and inhibiting acetylcholinesterase would worsen symptoms rather than improve them. (C) Stimulate acetylcholine receptors: Stimulating acetylcholine receptors would further exacerbate Parkinsonian symptoms, as there is already excess cholinergic activity due to dopamine depletion. This is why anticholinergic drugs (e.g., benztropine, trihexyphenidyl) are sometimes used to reduce tremors and rigidity in Parkinson’s disease. (D) Stimulate dopamine receptors: Levodopa itself does not directly stimulate dopamine receptors. Instead, it gets converted into dopamine, which then activates dopamine receptors in the striatum. However, dopamine agonists such as pramipexole and ropinirole can directly stimulate dopamine receptors (D2 receptors) and are also used in Parkinson’s treatment, particularly in younger patients or as adjunct therapy.",
      "correct_choice_id": 294374,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/30651971700305313/30651971700305313.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/30651971700305313/30651971700305313.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98883,
      "choices": [
        {
          "id": 294378,
          "text": "Considered to be typical antipsychotic agents"
        },
        {
          "id": 294379,
          "text": "Have fewer extrapyramidal symptoms than first generation agents"
        },
        {
          "id": 294380,
          "text": "Low risk of development of diabetes mellitus"
        },
        {
          "id": 294381,
          "text": "Low risk of development of hypercholesterolemia"
        }
      ],
      "text": "A 51-year-old man presents to hospital with long-standing schizophrenia is hospitalized for a symptom exacerbation. The psychiatrist places him on a second-generation antipsychotic agent. Characteristics of this agent include which of the following?",
      "unique_key": "Q1344212",
      "question_audio": null,
      "question_video": null,
      "map_id": 34904763,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Have fewer extrapyramidal symptoms than first-generation agents. Second-generation antipsychotics (SGAs), also known as atypical antipsychotics, are commonly used to treat schizophrenia due to their lower risk of extrapyramidal side effects (EPS) compared to first-generation antipsychotics (FGAs). FGAs primarily block dopamine D2 receptors, which leads to movement disorders such as tardive dyskinesia, dystonia, akathisia, and parkinsonism. In contrast, SGAs block both serotonin (5-HT1A) and dopamine (D2) receptors, leading to less dopamine blockade in the nigrostriatal pathway, which reduces EPS risk. This makes SGAs preferred for long-term treatment of schizophrenia, especially in patients at high risk for movement disorders. Explanation of Incorrect Options: (A) Considered to be typical antipsychotic agents: SGAs are atypical antipsychotics, not typical (first-generation) antipsychotics. FGAs (e.g., haloperidol, chlorpromazine, fluphenazine) act primarily by blocking dopamine D2 receptors and are associated with higher rates of EPS. SGAs (e.g., clozapine, risperidone, olanzapine, quetiapine, aripiprazole) have a broader mechanism, blocking both serotonin (5-HT1A) and dopamine D2 receptors, reducing EPS risk. (C) Low risk of development of diabetes mellitus: This statement is incorrect because many SGAs, particularly clozapine and olanzapine, have a high risk of metabolic side effects, including weight gain, insulin resistance, and diabetes mellitus. These effects are due to serotonin (5-HT1A) and histamine receptor blockade, which increase appetite and metabolic dysfunction. (D) Low risk of development of hypercholesterolemia: This is also incorrect, as SGAs, especially clozapine, olanzapine, and quetiapine, are associated with dyslipidemia and hypercholesterolemia. This metabolic dysfunction is linked to their effects on serotonin (5-HT1A) and histamine receptors, leading to weight gain and increased triglyceride levels. Aripiprazole and ziprasidone have lower metabolic risks, but overall, SGAs are more likely to cause hypercholesterolemia than FGAs.",
      "correct_choice_id": 294379,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/55115871700305398/55115871700305398.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/55115871700305398/55115871700305398.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98884,
      "choices": [
        {
          "id": 294382,
          "text": "Carbidopa"
        },
        {
          "id": 294383,
          "text": "Donepezil"
        },
        {
          "id": 294384,
          "text": "Benztropine"
        },
        {
          "id": 294385,
          "text": "Selegiline"
        }
      ],
      "text": "A patient with Parkinson's disease is treated with a medication that increases dopamine levels. Which of the following medications is most appropriate for this condition?",
      "unique_key": "Q2585828",
      "question_audio": null,
      "question_video": null,
      "map_id": 34265810,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Selegiline Selegiline is a selective monoamine oxidase type B (MAO-B) inhibitor, which prevents the breakdown of dopamine in the brain, increasing its availability in the nigrostriatal pathway. Since dopamine deficiency is the hallmark of Parkinson’s disease, selegiline helps to enhance dopamine levels and reduce motor symptoms. It is often used as an adjunct to levodopa therapy to prolong its effect and delay disease progression. Incorrect Options: (A) Carbidopa – Incorrect Carbidopa is a dopamine decarboxylase inhibitor that prevents the peripheral conversion of levodopa to dopamine, ensuring more levodopa reaches the brain. However, it does not increase dopamine levels on its own and is only effective when used in combination with levodopa (e.g., in levodopa-carbidopa preparations). (B) Donepezil – Incorrect Donepezil is a cholinesterase inhibitor used to treat Alzheimer’s disease by increasing acetylcholine levels in the brain. It has no role in Parkinson’s disease, as dopamine, not acetylcholine, is the primary deficient neurotransmitter. (C) Benztropine – Incorrect Benztropine is an anticholinergic drug used to manage tremors and rigidity in Parkinson’s disease by blocking excess acetylcholine activity in the basal ganglia. However, it does not increase dopamine levels and is not the best choice for directly addressing dopamine deficiency.",
      "correct_choice_id": 294385,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62612711727532764/62612711727532764.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62612711727532764/62612711727532764.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98885,
      "choices": [
        {
          "id": 294386,
          "text": "Paroxetine"
        },
        {
          "id": 294387,
          "text": "Bupropion"
        },
        {
          "id": 294388,
          "text": "Mirtazapine"
        },
        {
          "id": 294389,
          "text": "Venlafaxine"
        }
      ],
      "text": "A 32-year-old woman with a history of generalized anxiety disorder (GAD) presents to her primary care physician. She reports that her current medication, sertraline, is effective for her anxiety but has caused significant weight gain and sexual dysfunction. The physician decides to switch her to another medication. Which of the following would be the most appropriate alternative for her condition?",
      "unique_key": "Q2692291",
      "question_audio": null,
      "question_video": null,
      "map_id": 34942203,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Bupropion Bupropion is an atypical antidepressant that acts as a norepinephrine-dopamine reuptake inhibitor (NDRI). Unlike selective serotonin reuptake inhibitors (SSRIs) such as sertraline, bupropion does not cause significant weight gain or sexual dysfunction. In fact, it may promote weight loss and improve sexual function, making it an appropriate choice for this patient, who is experiencing these side effects from sertraline. Bupropion is often used as an alternative to SSRIs in patients who cannot tolerate their side effects, though it is not the first-line treatment for generalized anxiety disorder (GAD) due to its stimulant-like properties, which may worsen anxiety in some cases. However, for patients with GAD and coexisting depressive symptoms, bupropion can be a suitable option. Incorrect Options: (A) Paroxetine – Incorrect Paroxetine is another SSRI, like sertraline, and is also associated with weight gain and sexual dysfunction. Switching from sertraline to paroxetine would not resolve the patient’s complaints and may even worsen weight gain due to its greater antihistaminergic effects. (C) Mirtazapine – Incorrect Mirtazapine is a noradrenergic and specific serotonergic antidepressant (NaSSA). While it is effective in treating anxiety and depression, it is highly associated with weight gain due to its strong antihistaminergic (H1 receptor-blocking) activity. Since the patient is concerned about weight gain, mirtazapine would not be an ideal choice. (D) Venlafaxine – Incorrect Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that is effective for both GAD and depression. However, it still has a significant risk of sexual dysfunction and can also cause dose-dependent hypertension, which may not be desirable. Given that bupropion avoids both sexual dysfunction and weight gain, it is a better choice for this patient.",
      "correct_choice_id": 294387,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26293091727679634/26293091727679634.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26293091727679634/26293091727679634.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98886,
      "choices": [
        {
          "id": 294390,
          "text": "Increase lithium dosage"
        },
        {
          "id": 294391,
          "text": "Continue current lithium dosage and recheck in one week"
        },
        {
          "id": 294392,
          "text": "Discontinue lithium and monitor closely"
        },
        {
          "id": 294393,
          "text": "Administer intravenous fluids and monitor renal function"
        }
      ],
      "text": "A 45-year-old male patient with a long history of bipolar disorder has been stabilized on lithium therapy. He presents to the clinic for a routine check-up. His serum lithium level is found to be 1.6 mEq/L. He reports feeling more lethargic than usual and has experienced some tremors. What is the most appropriate next step in management?",
      "unique_key": "Q7944639",
      "question_audio": null,
      "question_video": null,
      "map_id": 34230417,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Administer intravenous fluids and monitor renal function Lithium toxicity occurs when serum lithium levels rise above the therapeutic range (0.6–1.2 mEq/L). A level of 1.6 mEq/L is above the upper limit and may lead to toxicity, especially if accompanied by symptoms such as lethargy and tremors. Since lithium is primarily excreted by the kidneys, its clearance can be affected by dehydration, renal impairment, or drug interactions (e.g., NSAIDs, ACE inhibitors, diuretics). Management of mild lithium toxicity (1.5–2.0 mEq/L) involves: Discontinuation of lithium Administration of intravenous fluids to enhance renal clearance Monitoring of renal function and electrolyte levels Supportive care for symptoms In more severe cases (levels >2.5 mEq/L), hemodialysis may be required. Incorrect Options: (A) Increase lithium dosage – Incorrect Since the patient's lithium level is already above the therapeutic range and he is experiencing symptoms of toxicity, increasing the dose would further worsen toxicity and is not appropriate. (B) Continue current lithium dosage and recheck in one week – Incorrect Given the elevated lithium level and the presence of symptoms, continuing the current dose without intervention could lead to worsening toxicity, including confusion, ataxia, and even seizures. Immediate action is needed rather than waiting for a re-evaluation. (C) Discontinue lithium and monitor closely – Incorrect While discontinuing lithium is necessary, monitoring alone is not sufficient. The administration of IV fluids is crucial to enhance renal excretion and prevent further toxicity. Simply stopping the drug without addressing the underlying issue could delay recovery.",
      "correct_choice_id": 294393,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75163861727679660/75163861727679660.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75163861727679660/75163861727679660.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98887,
      "choices": [
        {
          "id": 294394,
          "text": "Serotonin syndrome"
        },
        {
          "id": 294395,
          "text": "Hypertensive crisis"
        },
        {
          "id": 294396,
          "text": "Neuroleptic malignant syndrome"
        },
        {
          "id": 294397,
          "text": "QT interval prolongation"
        }
      ],
      "text": "A 60-year-old female with a history of depression is being treated with fluoxetine. After several months, she begins to experience increased anxiety and agitation. Upon review, her physician notes that she has recently started taking sumatriptan for migraine headaches. What is the most likely pharmacological interaction occurring in this patient?",
      "unique_key": "Q7564128",
      "question_audio": null,
      "question_video": null,
      "map_id": 34790925,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Serotonin syndrome Serotonin syndrome occurs due to excessive serotonergic activity in the central nervous system, often caused by the concurrent use of multiple serotonergic drugs. In this case, the patient is taking fluoxetine (a selective serotonin reuptake inhibitor, SSRI) and sumatriptan (a serotonin receptor agonist, 5-HT1B/1D agonist). The combination of these two drugs increases serotonin levels significantly, leading to serotonin syndrome. Symptoms of serotonin syndrome include: Neuromuscular hyperactivity: Tremors, clonus, hyperreflexia, muscle rigidity Autonomic dysfunction: Hypertension, hyperthermia, diaphoresis Altered mental status: Anxiety, agitation, confusion, delirium This patient's increased anxiety and agitation suggest early signs of serotonin syndrome, which can progress to severe hyperthermia, seizures, and cardiovascular instability if not managed promptly. Incorrect Options: (B) Hypertensive crisis – Incorrect Hypertensive crisis occurs due to excessive catecholamine activity, often seen with: Monoamine oxidase inhibitors (MAOIs) combined with tyramine-containing foods or sympathomimetic drugs Sudden discontinuation of antihypertensive drugs (e.g., clonidine withdrawal) While sumatriptan can cause mild increases in blood pressure, fluoxetine does not significantly contribute to a hypertensive crisis. The absence of severe hypertension and associated symptoms (e.g., headache, vision changes, chest pain) makes this diagnosis unlikely. (C) Neuroleptic malignant syndrome (NMS) – Incorrect NMS is a life-threatening reaction to dopamine-blocking drugs (e.g., antipsychotics such as haloperidol, risperidone). Characterized by severe muscle rigidity (\"lead-pipe rigidity\"), fever, autonomic instability, and altered mental status. Unlike serotonin syndrome, NMS lacks hyperreflexia or clonus. Since fluoxetine and sumatriptan do not affect dopamine receptors, NMS is not the correct diagnosis. (D) QT interval prolongation – Incorrect Fluoxetine is known to prolong the QT interval, but sumatriptan does not significantly contribute to this effect. QT prolongation can lead to torsades de pointes, presenting with syncope or palpitations rather than anxiety and agitation. The patient's symptoms are more suggestive of serotonin syndrome rather than cardiac arrhythmia.",
      "correct_choice_id": 294394,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/39996281727679695/39996281727679695.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/39996281727679695/39996281727679695.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98888,
      "choices": [
        {
          "id": 294398,
          "text": "Serotonin syndrome"
        },
        {
          "id": 294399,
          "text": "Acute withdrawal from sertraline"
        },
        {
          "id": 294400,
          "text": "Return of panic disorder symptoms"
        },
        {
          "id": 294401,
          "text": "Cardiac arrhythmia"
        }
      ],
      "text": "A 38-year-old woman with a history of panic disorder presents to the emergency department with palpitations, shortness of breath, and a feeling of impending doom. She reports that she has not been taking her prescribed sertraline for the past two weeks due to feeling better. What is the most likely reason for her current symptoms?",
      "unique_key": "Q5240336",
      "question_audio": null,
      "question_video": null,
      "map_id": 34616605,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Return of panic disorder symptoms Panic disorder is a chronic condition that requires consistent treatment to prevent recurrence. Sertraline, a selective serotonin reuptake inhibitor (SSRI), is commonly prescribed for anxiety disorders, including panic disorder. The patient discontinued sertraline for two weeks, thinking she no longer needed it. However, SSRIs do not cure panic disorder but rather help manage symptoms. Stopping sertraline abruptly does not immediately eliminate the underlying condition, and panic symptoms can return once the medication is out of her system. The palpitations, shortness of breath, and sense of impending doom are classic features of a panic attack, suggesting a relapse rather than a drug-related side effect. Incorrect Options: (A) Serotonin syndrome – Incorrect Serotonin syndrome occurs due to excessive serotonin activity, often from overdose or drug interactions (e.g., combining SSRIs with MAOIs or triptans). Symptoms include hyperthermia, muscle rigidity, confusion, tremors, and autonomic instability—which this patient does not exhibit. Since she stopped sertraline, serotonin levels would decrease, making serotonin syndrome unlikely. (B) Acute withdrawal from sertraline – Incorrect SSRIs like sertraline can cause discontinuation syndrome, but sertraline has a long half-life (about 24 hours, with an active metabolite lasting even longer). Withdrawal symptoms (dizziness, flu-like symptoms, irritability) typically occur after stopping shorter-acting SSRIs like paroxetine, whereas panic-like symptoms are more consistent with relapse rather than withdrawal. (D) Cardiac arrhythmia – Incorrect While palpitations can be associated with arrhythmias, this patient has a history of panic disorder, which is a more likely explanation. Sertraline is generally not cardiotoxic and does not significantly prolong QT intervals at therapeutic doses. There are no other cardiac symptoms like syncope or chest pain to suggest an arrhythmic event.",
      "correct_choice_id": 294400,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/68785521727679736/68785521727679736.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/68785521727679736/68785521727679736.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98889,
      "choices": [
        {
          "id": 294402,
          "text": "Buspirone withdrawal"
        },
        {
          "id": 294403,
          "text": "Drug interaction between buspirone and the new antidepressant"
        },
        {
          "id": 294404,
          "text": "Exacerbation of anxiety symptoms"
        },
        {
          "id": 294405,
          "text": "Hypersensitivity reaction to buspirone"
        }
      ],
      "text": "A 30-year-old woman with a history of generalized anxiety disorder is treated with buspirone. She presents to the clinic with complaints of dizziness and nausea, which have worsened since starting the medication. The physician reviews her medication list and notes that she has recently started taking a new antidepressant. Which of the following is the most likely reason for her symptoms?",
      "unique_key": "Q9171984",
      "question_audio": null,
      "question_video": null,
      "map_id": 34798156,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Drug interaction between buspirone and the new antidepressant Buspirone is an anxiolytic that acts as a partial agonist at serotonin (5-HT1A) receptors and is commonly used to treat generalized anxiety disorder (GAD). It is metabolized by the CYP3A4 enzyme, and certain antidepressants—especially selective serotonin reuptake inhibitors (SSRIs) or monoamine oxidase inhibitors (MAOIs)—can interact with buspirone, leading to serotonin syndrome or increased side effects like dizziness, nausea, and agitation. If the new antidepressant is an SSRI (e.g., fluoxetine, sertraline) or an MAOI (e.g., phenelzine, tranylcypromine), this interaction could increase serotonin activity, leading to the patient's symptoms. Additionally, some antidepressants inhibit CYP3A4, reducing the metabolism of buspirone and leading to increased drug levels and worsening side effects. Incorrect Options: (A) Buspirone withdrawal – Incorrect Buspirone has a gradual onset of action and does not cause physical dependence or withdrawal symptoms like benzodiazepines. The patient is currently taking buspirone, not discontinuing it, making withdrawal an unlikely cause. (C) Exacerbation of anxiety symptoms – Incorrect While anxiety can cause dizziness and nausea, this patient reports worsening symptoms since starting the new antidepressant, making a drug interaction a more likely explanation than anxiety worsening on its own. Additionally, buspirone is not known to acutely exacerbate anxiety—instead, it takes 1–2 weeks to show its full effects. (D) Hypersensitivity reaction to buspirone – Incorrect Hypersensitivity reactions typically present with rash, itching, swelling, or anaphylactic symptoms, rather than just dizziness and nausea. Since the patient has been taking buspirone and only recently developed symptoms, an interaction with the new medication is the more probable cause.",
      "correct_choice_id": 294403,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/64476671727679774/64476671727679774.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/64476671727679774/64476671727679774.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98890,
      "choices": [
        {
          "id": 294406,
          "text": "Progression of Parkinson’s disease"
        },
        {
          "id": 294407,
          "text": "Levodopa/carbidopa overdose"
        },
        {
          "id": 294408,
          "text": "Adverse effects of levodopa/carbidopa"
        },
        {
          "id": 294409,
          "text": "Interaction with an over-the-counter medication"
        }
      ],
      "text": "A 55-year-old male patient with Parkinson’s disease is treated with levodopa/carbidopa. He presents with new-onset hallucinations and confusion after several months of stable treatment. What is the most likely cause of these symptoms?",
      "unique_key": "Q7695186",
      "question_audio": null,
      "question_video": null,
      "map_id": 34067181,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Adverse effects of levodopa/carbidopa Levodopa, the precursor to dopamine, is the most effective treatment for Parkinson’s disease, but long-term use can lead to neuropsychiatric side effects, including hallucinations, confusion, agitation, and psychosis. These symptoms occur due to excessive dopaminergic stimulation in the mesolimbic pathway, which is involved in cognition and perception. Carbidopa helps reduce peripheral side effects (e.g., nausea, hypotension) but does not prevent central side effects like hallucinations, as it does not cross the blood-brain barrier. Older patients are especially prone to these adverse effects due to reduced dopamine receptor regulation and brain reserve capacity. Incorrect Options: (A) Progression of Parkinson’s disease – Incorrect While Parkinson’s disease can cause cognitive decline and dementia, hallucinations and acute confusion are more likely due to medication side effects rather than the natural course of the disease. Parkinson’s dementia typically presents gradually over time, rather than as a sudden-onset symptom after months of stable treatment. (B) Levodopa/carbidopa overdose – Incorrect Overdose would cause severe dyskinesias (involuntary movements), nausea, tachycardia, and extreme agitation, not just hallucinations and confusion. The patient’s symptoms are more characteristic of chronic dopaminergic overstimulation, which occurs even at therapeutic doses in susceptible individuals. (D) Interaction with an over-the-counter medication – Incorrect Some medications, such as anticholinergics (e.g., diphenhydramine), decongestants, or dopamine agonists, can worsen confusion in Parkinson’s patients. However, given that levodopa/carbidopa is known to cause these neuropsychiatric side effects, it remains the most likely explanation without evidence of a new medication being introduced.",
      "correct_choice_id": 294408,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/76205691727679805/76205691727679805.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/76205691727679805/76205691727679805.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98891,
      "choices": [
        {
          "id": 294410,
          "text": "Increase the dose of donepezil"
        },
        {
          "id": 294411,
          "text": "Discontinue donepezil"
        },
        {
          "id": 294412,
          "text": "Add memantine to her treatment regimen"
        },
        {
          "id": 294413,
          "text": "Switch to another cholinesterase inhibitor"
        }
      ],
      "text": "A 65-year-old woman with a history of Alzheimer’s disease is prescribed donepezil. After six months, her caregiver reports that she has become increasingly forgetful and agitated. The physician suspects that her Alzheimer’s is progressing. Which of the following is the most appropriate next step in management?",
      "unique_key": "Q8667383",
      "question_audio": null,
      "question_video": null,
      "map_id": 34836901,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Add memantine to her treatment regimen Alzheimer’s disease is a progressive neurodegenerative disorder, and despite treatment with cholinesterase inhibitors like donepezil, symptoms often worsen over time. Memantine, an NMDA receptor antagonist, is typically added in moderate to severe cases to help slow disease progression and improve cognitive function by reducing excitotoxic neuronal damage caused by excessive glutamate activity. Memantine is well-tolerated and may help reduce agitation, confusion, and functional decline in later stages of Alzheimer's. Combining donepezil and memantine is a standard approach for managing worsening symptoms when a patient remains on cholinesterase inhibitors. Incorrect Options: (A) Increase the dose of donepezil – Incorrect While dose escalation (e.g., from 5 mg to 10 mg daily) can be beneficial in early stages, the patient’s symptoms are worsening despite treatment, indicating the need for an additional mechanism of action rather than just increasing cholinergic activity. Higher doses of donepezil may also increase the risk of gastrointestinal side effects (nausea, diarrhea) and bradycardia. (B) Discontinue donepezil – Incorrect Stopping donepezil could lead to a rapid cognitive decline, as cholinergic deficits worsen in Alzheimer’s disease. It is recommended to continue cholinesterase inhibitors for as long as they provide cognitive and functional benefits. (D) Switch to another cholinesterase inhibitor – Incorrect Other cholinesterase inhibitors like rivastigmine or galantamine have similar mechanisms of action as donepezil. Switching would not significantly alter the course of the disease and is usually done only if the patient cannot tolerate donepezil. Instead, adding memantine provides a complementary approach by targeting glutamatergic excitotoxicity.",
      "correct_choice_id": 294412,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/76757521727679825/76757521727679825.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/76757521727679825/76757521727679825.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98892,
      "choices": [
        {
          "id": 294414,
          "text": "Digoxin fro heart failure"
        },
        {
          "id": 294415,
          "text": "Haloperidol for Tourette’s syndrome"
        },
        {
          "id": 294416,
          "text": "Levodopa for Parkinson’s disease"
        },
        {
          "id": 294417,
          "text": "Niacin for hypertriglyceridemia"
        }
      ],
      "text": "The patient should be told to avoid taking supplement vitamin B6 (pyridoxine) if he/she being treated with which of the following",
      "unique_key": "Q2911551",
      "question_audio": null,
      "question_video": null,
      "map_id": 34592611,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Levodopa is often administered with carbidopa, a drug that inhibits the peripheral decarboxylase, sparing levodopa for entry into the brain and whose actions are antagonized by pyridoxine.",
      "correct_choice_id": 294416,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/74356571727679871/74356571727679871.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/74356571727679871/74356571727679871.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98893,
      "choices": [
        {
          "id": 294418,
          "text": "Propranolol"
        },
        {
          "id": 294419,
          "text": "Sumatriptan"
        },
        {
          "id": 294420,
          "text": "Amitriptyline"
        },
        {
          "id": 294421,
          "text": "Gabapentin"
        }
      ],
      "text": "A 28-year-old woman diagnosed with major depressive disorder has been treated with fluoxetine for several months. She now presents with persistent headache, nausea, and lethargy. The physician suspects a drug interaction with her newly prescribed medication for migraine headaches. Which of the following medications is most likely to cause this interaction?",
      "unique_key": "Q7167850",
      "question_audio": null,
      "question_video": null,
      "map_id": 34509312,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Sumatriptan. Sumatriptan is a serotonin (5-HT1B/1D) receptor agonist used for the acute treatment of migraine attacks. It works by causing vasoconstriction of intracranial blood vessels and inhibiting the release of pro-inflammatory neuropeptides. However, when combined with fluoxetine, a selective serotonin reuptake inhibitor (SSRI), there is an increased risk of serotonin syndrome due to excess serotonergic activity in the central nervous system. The patient's symptoms—headache, nausea, and lethargy—are mild but could be early signs of serotonin syndrome, which, if severe, can progress to hyperreflexia, myoclonus, autonomic instability, and even life-threatening complications. Because of this risk, caution is advised when combining SSRIs with triptans, and patients should be closely monitored for signs of excessive serotonergic activity. Explanation of Incorrect Options: Option A - Propranolol: Incorrect. Propranolol is a non-selective beta-blocker commonly used for migraine prophylaxis and treatment of hypertension and anxiety. It does not increase serotonin levels and does not interact with fluoxetine in a way that would cause the patient's symptoms. Its side effects are more related to bradycardia, hypotension, and fatigue, rather than serotonin excess. Option C - Amitriptyline: Incorrect. Amitriptyline is a tricyclic antidepressant (TCA) often used for migraine prophylaxis and neuropathic pain. While TCAs do have some serotonergic activity, their primary mechanism involves norepinephrine reuptake inhibition and anticholinergic effects. Although combining SSRIs and TCAs can increase the risk of serotonin syndrome, amitriptyline is typically not used for acute migraine attacks and would not cause the immediate symptoms seen in this case. Option D - Gabapentin: Incorrect. Gabapentin is an anticonvulsant used to treat neuropathic pain and migraine prophylaxis. It does not affect serotonin levels and is not associated with serotonin syndrome. Common side effects of gabapentin include dizziness, sedation, and ataxia, but these do not explain the nausea and headache observed in this patient.",
      "correct_choice_id": 294419,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/47000831727680059/47000831727680059.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/47000831727680059/47000831727680059.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98894,
      "choices": [
        {
          "id": 294422,
          "text": "Continue lithium and monitor closely"
        },
        {
          "id": 294423,
          "text": "Discontinue lithium therapy"
        },
        {
          "id": 294424,
          "text": "Increase sodium intake and recheck lithium levels"
        },
        {
          "id": 294425,
          "text": "Switch to an alternative mood stabilizer"
        }
      ],
      "text": "A 34-year-old female with bipolar disorder has been stable on lithium therapy for years. She comes to the clinic for routine monitoring and her lab results show a serum lithium level of 1.2 mEq/L. She denies any symptoms but mentions that she has recently started a low-sodium diet for weight loss. What should the physician advise her?",
      "unique_key": "Q4605012",
      "question_audio": null,
      "question_video": null,
      "map_id": 34065972,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Increase sodium intake and recheck lithium levels. Lithium is primarily excreted by the kidneys, and its excretion is closely tied to sodium balance. When sodium intake is reduced, the kidneys compensate by increasing lithium reabsorption in the proximal tubules, leading to a higher lithium level in the blood. This can predispose patients to lithium toxicity, even if they do not have symptoms initially. Since this patient recently started a low-sodium diet, it is likely contributing to the elevated lithium levels (1.2 mEq/L, which is on the higher end of the therapeutic range). The best course of action is to advise her to increase her sodium intake and then monitor lithium levels closely to prevent toxicity. Explanation of Incorrect Options: Option A - Continue lithium and monitor closely: Incorrect. While close monitoring is essential, doing nothing about the reduced sodium intake could increase the risk of lithium toxicity. Without correcting the underlying cause (low sodium intake), lithium levels could continue to rise, potentially leading to nausea, tremors, confusion, and even life-threatening toxicity. Option B - Discontinue lithium therapy: Incorrect. There is no need to discontinue lithium in a stable patient who is asymptomatic and has a lithium level within the upper therapeutic range. Abrupt discontinuation of lithium can lead to relapse of bipolar symptoms, particularly manic episodes. Instead, addressing the dietary sodium intake is the appropriate intervention. Option D - Switch to an alternative mood stabilizer: Incorrect. There is no need to switch medications at this point. Lithium remains the gold-standard treatment for bipolar disorder, especially in preventing suicide and mood stabilization. Since the issue is related to dietary sodium intake, adjusting sodium consumption is a better first-line approach rather than switching to another mood stabilizer like valproate or lamotrigine.",
      "correct_choice_id": 294424,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/14031001727680095/14031001727680095.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/14031001727680095/14031001727680095.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98895,
      "choices": [
        {
          "id": 294426,
          "text": "Discontinue donepezil"
        },
        {
          "id": 294427,
          "text": "Increase the donepezil dose"
        },
        {
          "id": 294428,
          "text": "Add memantine"
        },
        {
          "id": 294429,
          "text": "Switch to rivastigmine"
        }
      ],
      "text": "A 60-year-old woman with Alzheimer’s disease has been receiving donepezil for six months. Her caregiver reports that she has become increasingly withdrawn and has lost interest in activities she once enjoyed. Which of the following changes in her medication regimen would be most appropriate?",
      "unique_key": "Q5998720",
      "question_audio": null,
      "question_video": null,
      "map_id": 34393506,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Add memantine. Memantine is an NMDA receptor antagonist used for moderate to severe Alzheimer’s disease (AD). It works by reducing excitotoxicity caused by excessive glutamate activity, which is believed to contribute to neurodegeneration in AD. Since the patient has been on donepezil (a cholinesterase inhibitor) for six months but is showing signs of worsening symptoms (withdrawal and loss of interest in activities), adding memantine can provide additional cognitive and behavioral benefits. Combination therapy with donepezil and memantine has been shown to improve cognitive function and daily living activities in moderate to severe AD. Explanation of Incorrect Options: Option A - Discontinue donepezil: Incorrect. Donepezil is a cholinesterase inhibitor that helps improve cognitive function and slow disease progression in AD. Stopping it abruptly could lead to further cognitive decline and worsening symptoms. Instead, the better approach is augmenting treatment with memantine rather than discontinuing donepezil. Option B - Increase the donepezil dose: Incorrect. While dose escalation is sometimes appropriate, donepezil is usually titrated up to a maximum of 10 mg daily. If the patient is already on the maximum effective dose, increasing it further will not provide additional benefit and may increase the risk of side effects like nausea, diarrhea, and bradycardia. Instead, memantine should be added for better symptom control. Option D - Switch to rivastigmine: Incorrect. Rivastigmine is another cholinesterase inhibitor, similar to donepezil. Switching from donepezil to rivastigmine would not necessarily provide additional benefit. Since the patient’s symptoms are progressing despite donepezil, the more appropriate step is to add memantine rather than switching to another drug in the same class.",
      "correct_choice_id": 294428,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/67601871727680233/67601871727680233.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/67601871727680233/67601871727680233.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 98896,
      "choices": [
        {
          "id": 294430,
          "text": "Glatiramer acetate"
        },
        {
          "id": 294431,
          "text": "Natalizumab"
        },
        {
          "id": 294432,
          "text": "Azathioprine"
        },
        {
          "id": 294433,
          "text": "Methotrexate"
        }
      ],
      "text": "A 40-year-old male with multiple sclerosis is experiencing increased frequency of relapses despite treatment with interferon beta. His neurologist considers adding a different immunomodulatory agent. Which of the following medications is known for its efficacy in reducing relapse rates in multiple sclerosis?",
      "unique_key": "Q8522667",
      "question_audio": null,
      "question_video": null,
      "map_id": 34336572,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Natalizumab. Natalizumab is a monoclonal antibody that targets ?4-integrin, preventing leukocyte migration across the blood-brain barrier. It is highly effective in reducing relapse rates and slowing disease progression in patients with relapsing-remitting multiple sclerosis (RRMS) who continue to experience relapses despite first-line treatment, such as interferon beta. Due to its potent immunosuppressive effects, natalizumab is generally reserved for patients with more aggressive MS or those who have failed other therapies. However, it carries a risk of progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection caused by JC virus reactivation, necessitating careful monitoring. Explanation of Incorrect Options: Option A - Glatiramer acetate: Incorrect. Glatiramer acetate is another first-line treatment for RRMS, similar to interferon beta. However, since the patient is already experiencing frequent relapses despite interferon beta, switching to glatiramer acetate would likely not provide significant additional benefit. Natalizumab is preferred in cases of treatment failure due to its higher efficacy in relapse reduction. Option C - Azathioprine: Incorrect. Azathioprine is an immunosuppressant that has been used in MS, but it is less effective than newer disease-modifying therapies (DMTs) like natalizumab. It is typically considered only in resource-limited settings or when other MS treatments are contraindicated. Given the availability of more effective options, azathioprine is not the best choice in this scenario. Option D - Methotrexate: Incorrect. Methotrexate is an immunosuppressant used in autoimmune diseases like rheumatoid arthritis and psoriasis, but its role in MS is limited. It is not a first-line or preferred treatment for MS, as it has weaker efficacy in reducing relapse rates compared to disease-modifying therapies such as interferon beta, glatiramer acetate, and natalizumab.",
      "correct_choice_id": 294431,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    }
  ]
}